These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9308904)

  • 21. Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants.
    Zhang YT; Zheng QS; Pan J; Zheng RL
    Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):53-8. PubMed ID: 15379780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
    Carlone NA; Cuffini AM; Forno-Pizzoglio M; Aragno M
    G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
    Werner H; Heizmann W; Luft G
    Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxalate at physiological urine concentrations induces oxidative injury in renal epithelial cells: effect of α-tocopherol and ascorbic acid.
    Thamilselvan V; Menon M; Thamilselvan S
    BJU Int; 2014 Jul; 114(1):140-50. PubMed ID: 24460843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactive effects of polyphenols, tocopherol and ascorbic acid on the Cu2+-mediated oxidative modification of human low density lipoproteins.
    Yeomans VC; Linseisen J; Wolfram G
    Eur J Nutr; 2005 Oct; 44(7):422-8. PubMed ID: 15827683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ascorbic acid on oxidative system and transient evoked otoacoustic emissions in rabbits exposed to noise.
    Dereköy FS; Köken T; Yilmaz D; Kahraman A; Altuntaş A
    Laryngoscope; 2004 Oct; 114(10):1775-9. PubMed ID: 15454771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
    Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
    Rodríguez JR; Hernández NI; Ramírez-Ronda CH; Nevárez M
    Bol Asoc Med P R; 1985 Jun; 77(6):242-4. PubMed ID: 3931655
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of protein carbonyl formation and lipid peroxidation by glutathione in rat liver microsomes.
    Palamanda JR; Kehrer JP
    Arch Biochem Biophys; 1992 Feb; 293(1):103-9. PubMed ID: 1731626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The carbonyl content of specific plasma proteins is decreased by dietary copper deficiency in rats.
    Cockell KA; Belonje B
    J Nutr; 2002 Sep; 132(9):2514-8. PubMed ID: 12221202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
    Verbist L
    Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion.
    Van der Vliet A; Smith D; O'Neill CA; Kaur H; Darley-Usmar V; Cross CE; Halliwell B
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):295-301. PubMed ID: 7945255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
    Trager GM; White GW; Zimelis VM; Bryk DA; Panwalker AP
    Chemotherapy; 1981; 27(1):34-8. PubMed ID: 6260435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
    Woolfrey BF; Fox JM; Quall CO
    J Antimicrob Chemother; 1981 Sep; 8(3):205-11. PubMed ID: 6270052
    [No Abstract]   [Full Text] [Related]  

  • 36. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro and in-vivo efficacy of ceftriaxone, moxalactam, and chloramphenicol against Haemophilus influenzae type b.
    Connor E; Melick C; Yogev R
    J Antimicrob Chemother; 1982 Dec; 10(6):517-25. PubMed ID: 6298172
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in-vitro activity of moxalactam and cefotaxime against isolates from blood culture.
    Ramirez-Ronda CH; Nevarez M; Saavedra S; Bermudez RH
    J Antimicrob Chemother; 1981 Jun; 7(6):629-35. PubMed ID: 6265427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.